European Distribution Center Motiva BV

Motiva NL B. V. is a medical device company specializing in advanced breast augmentation technologies, providing innovative silicone gel-filled breast implants that enhance aesthetic outcomes in breast surgery. Motiva NL B.

V. operates in the medical device sector, focusing on breast augmentation solutions. The company has not publicly indicated any significant strategic pivots. Motiva NL B.

V. is based in the Netherlands and has completed 1 deal as of October 1, 2024. The founder's details are not disclosed. Motiva® specializes in advanced breast augmentation technologies, primarily through its trademarked product offerings, including the Motiva SmoothSilk® Round and Motiva SmoothSilk Ergonomix® silicone gel-filled breast implants, which have received FDA approval for augmentation indications.

These implants are designed to closely mimic the look, feel, and movement of natural breast tissue, providing a balanced softness and firmness for an aesthetically pleasing result. The company's products address the needs of individuals seeking breast enhancement, reconstruction, or correction after cancer surgery, with an emphasis on safety and reduced complication rates, boasting less than 1% device-related complications. Motiva® products are marketed and sold in various international markets, including the United States, Europe, and Latin America, catering to both consumers and medical professionals, such as plastic surgeons, who play a crucial role in the decision-making process for patients. Motiva® operates on a B2B model, selling its products directly to certified surgeons and medical facilities, who subsequently offer these implants to their patients.

The transaction structure typically involves initial consultations where surgeons evaluate the needs of their patients and recommend appropriate products, followed by surgical procedures where the implants are used. Pricing strategies for individual implants and associated services are established through partnerships with medical professionals, ensuring that the products meet the necessary regulatory standards and market demands. The company’s flagship products, including the Motiva SmoothSilk® implants, contribute to its revenue by being integrated into surgical packages offered by healthcare providers, which may include warranties and post-operative support as part of the overall service offering. In October 2024, Establishment Labs S.

A. acquired Motiva Benelux B. V. The acquisition enables Establishment Labs S.

A. to strengthen its distribution network in Europe. This strategic move reflects plans for enhancing product availability and expanding market reach across European territories.